Authors: CZIRAKY MJ MEHRA IV WILSON MD BAKRIS GL

Citation: Mj. Cziraky et al., CURRENT ISSUES IN TREATING THE HYPERTENSIVE PATIENT WITH DIABETES - FOCUS ON DIABETIC NEPHROPATHY, The Annals of pharmacotherapy, 30(7-8), 1996, pp. 791-801

Authors: SPINLER SA CZIRAKY MJ

Citation: Sa. Spinler et Mj. Cziraky, LIPOPROTEIN(A) - PHYSIOLOGICAL-FUNCTION, ASSOCIATION WITH ATHEROSCLEROSIS, AND EFFECTS OF LIPID-LOWERING DRUG-THERAPY, The Annals of pharmacotherapy, 28(3), 1994, pp. 343-351

Authors: NICHOLSON CD MEULEMAN DG MAGNANI HN EGBERTS JFM LEIBOWITZ DA SPINLER SA CZIRAKY MJ

Citation: Cd. Nicholson et al., DANAPAROID IS NOT A LOW-MOLECULAR-WEIGHT HEPARIN, American journal of hospital pharmacy, 51(16), 1994, pp. 2049-2050

Authors: SPINLER SA CZIRAKY MJ

Citation: Sa. Spinler et Mj. Cziraky, DANAPAROID IS NOT A LOW-MOLECULAR-WEIGHT HEPARIN, American journal of hospital pharmacy, 51(16), 1994, pp. 2050-2050

Authors: CZIRAKY MJ SPINLER SA

Citation: Mj. Cziraky et Sa. Spinler, LOW-MOLECULAR-WEIGHT HEPARINS FOR THE TREATMENT OF DEEP-VEIN THROMBOSIS, Clinical pharmacy, 12(12), 1993, pp. 892-899